Paydirt
AL
Insider

ADAR1 Capital Management, LLC

10% owner

ADAR1 Capital Management, LLC (10% owner) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 9 priced purchase filings, the average 21-session return was +5.2% from execution and +12.8% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+5.2%
avg across 9 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+12.8%
same 9 filings, from disclosure
Filings, ttm
10
10 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.5M
shares × price, as filed
Last traded
Oct 21
Filed Oct 21

Median ADV $7.2M across their filed names

Impact on $10,000 · 12M
$17,680 (+76.8%)
S&P 500 $10,907 (+9.1%) · 67.7 pts ahead
$20.9k$15.1k$9.3kNov 10 2025May 12Nov 6
ADAR1 Capital Management, LLC S&P 500

Derived: compounded across filings from disclosure dates · past 12 months

Open performance→
Volume by month
$4.7M$2.3M$0Dec 2024Jun 2025Dec 2025Jun 2026May 2026 · buys $4.7MAug 2026 · buys $3.4MSep 2026 · buys $3.0MOct 2026 · buys $1.5M
Buys $12.5M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names
RLYB Rallybio Corporation RLYB · 4 buys · 0 sells 4 filings TENX Tenax Therapeutics, Inc. TENX · 4 buys · 0 sells 4 filings INM InMed Pharmaceuticals Inc. INM · 1 buy · 0 sells 1 filing NXTC NextCure, Inc. NXTC · 1 buy · 0 sells 1 filing
Recent filings
RLYBPURCHASE Rallybio Corporation View filing → $629K
44,900 sh across 2 lots
Exec May 11
Filed May 13 · 9:22 PM ET
RLYBPURCHASE Rallybio Corporation View filing → $2.1M
152,005 sh across 2 lots
Exec May 4
Filed May 6 · 9:32 PM ET